News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

JS Genetics Announce Launch of its Bloodless, Cheek Swab Test for Fragile X Syndrome


4/18/2012 10:19:21 AM

NEW HAVEN Conn., April 18, 2012 /PRNewswire/ -- JS Genetics announces the launch of XCAT-FX, its propitiatory buccal swab test for the detection of Fragile X syndrome. Fragile X syndrome is the most common cause of inherited intellectual disability (mental retardation) in males and a leading cause of infertility and fragile X-associated primary ovarian insufficiency in females. Fragile X is also the most common known genetic (single gene) cause of autism. This PCR based test can identify Fragile X in both males and female patients.

The result of XCAT-FX will typically be available within 3 business days following the receipt of the samples at JS Genetics' CLIA certified, CAP accredited laboratory.

"I am very pleased that we are now including Fragile X in the JS Genetics diagnostic menu," stated Henry Rinder MD, Medical Director of JS Genetics. "Fragile X testing will further enhance our laboratory's ability to aid physicians in making the sometimes difficult diagnosis of disorders of sex chromosomes, which also include Turner and Klinefelter syndromes and related sex chromosome aneuploidies."

About JS Genetics
For more information about JS Genetics or XCAT-FX visit www.jsgenetics.com. Physicians who would like to obtain testing kits at no charge can order at www.jsgenetics.com or call1-888-217-8947.

JS Genetics Inc., a private company, develops and markets proprietary, high value DNA diagnostic tests for medical conditions in newborns, children, and adolescents. (CLIA ID# 07D1091103; CAP# 72115351)

SOURCE JS Genetics


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES